The Central Drugs Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma India's liver cancer drug Tremelimumab Concentrate to be administered intravenously, the company said on Thursday.The approval for Tremelimumab in .
New Delhi, June 1 (IANS) The Central Drugs Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma India's liver cancer drug Tremelimumab